Status:
ACTIVE_NOT_RECRUITING
Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Skin Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial studies the impact of a 12-month invention focused on early detection of skin cancer and timely follow up in patients who underwent stem cell transplant and their primary care providers. So...
Detailed Description
PRIMARY OBJECTIVES: I. Determine the impact of patient activation and education (PAE, N=360) alone or with physician activation (PAE+Phys, N=360) on skin cancer screening and health promotion practic...
Eligibility Criteria
Inclusion
- Have undergone autologous or allogeneic hematopoietic stem cell transplantation (HCT) at City of Hope (COH)
- Are 2 years (yrs) to 5 yrs (+/- 3 months \[m\]) after HCT
- Have seen a primary care provider (PCP) in the previous 12 m (expected \> 95% of all eligible) or planning to do so in next 12 m
- Have a mobile phone with the ability to receive text messages
- Can fluently read and write in English or Spanish
- Can understand and sign the study-specific Informed Consent Form (ICF)
Exclusion
- Patients who have evidence of active hematologic malignancy or acute illness that would limit study participation
Key Trial Info
Start Date :
October 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2026
Estimated Enrollment :
840 Patients enrolled
Trial Details
Trial ID
NCT04358276
Start Date
October 30 2020
End Date
March 31 2026
Last Update
February 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Medical Center
Duarte, California, United States, 91010